李志裕 教授 博士
1988年本科毕业于中国药科大学，1991年获得中国药科大学药物化学硕士学位，2000年获得中国药科大学药物化学博士学位，2001年至2002年在University della Carabulia进行博士后研究工作；1991年硕士毕业后于中国药科大学任教至今。
主要从事天然产物全合成、半合成、药物合成和构效关系的研究，具有多年的科研实践经验，具备独立开展科研课题的研究能力。主持完成了两项江苏省自然基金项目两项，主持完成南京市留学人员科技活动择优项目1项，参加国家自然科学基金3项、重大医药专项1项及中医药管理局项目1项，主持横向课题15项，近两年来，在国内外学术刊物SCI、及核心期刊上已发表论文六十余篇，申请专利十六项，其中十四项获得授权。主编教材两部。获得江苏省科学进步奖三项，多次获得国家教育部及江苏省教学成果奖。
近年发表的论文
1、 NA LU, LIBIN WEI, DANDAN GONG, YUAN GAO,QINSHENG DAI, ZHIYU LI and QINGLONG GUO VI-16, a newly synthesized flavonoid, induces apoptosis through the mitochondrial pathway in human hepatoma cells ONCOLOGY REPORTS 27: 873-879, 2012（通讯作者)
2、 Wei Fu , Jubo Wang, Liqin Yu , Li Zhao , Na Lub, Qidong You , Qinglong Guo , Zhiyu Li* Synthesis and biological evaluation of 7-O-modified oroxylin A derivatives Bioorg、 Med、 Chem、 Lett、 22 (2012) 1118–1121（通讯作者)
3、 Xiaoyun Zhang, Rubing Wang, Li Zhao, Na Lu, Jubo Wang, Qidong You, Zhiyu Li*, Qinglong Guo Synthesis and biological evaluations of novel indenoisoquinolinesas topoisomerase I inhibitors Bioorg、 Med、 Chem、 Lett、 22 (2012) 1276–1281（通讯作者）
4、 Tian Wu, LeiQiang, Fei-Hong Chen,Qing Zhao,Zhen Yang, Mei-Juan Zou,Ya-Jing Sun, Zhi-Yu Li*, Qing-LongGuo* LFG-500, a newly synthesized flavonoid, induced a reactive oxygen species-mitochondria-mediated apoptosis in hepatocarcinoma cells Biomedicine & Preventive Nutrition 1 (2011) 132–138 通讯作者
5、 Liu W, Dai Q, Lu N, Wei L, Ha J, Rong J, Mu R, You Q, Li Z*, Guo Q、 LYG-202, a new flavonoid with a piperazine substitution, induces cell cycle arrest and apoptosis via regulating expression levels of p53 and p21WAF1/Cip1 in human colorectal carcinoma HCT-116 cells、 Biochem、 Cell Biol、 2011，89: 1–12通讯作者
6、 Zhi-Yu Li; Xin Cao; Xin Wang; Qing-Long Guo; Qi-Dong You Convenient Synthesis of Wogonin, A Flavonoid Natural Product with Extensive Pharmacological Activity Organic Preparations and Procedures International: The New Journal for Organic Synthesis, 2009 41,( 4), 327–330
7、 Zhiyu Li , Fuming Zhai , Li Zhao , Qinglong Guo , Qidong You ,Design and synthesis of N-methylmaleimide indolocarbazole bearing modified 2-acetamino acid moieties as Topoisomerase I inhibitors Bioorganic & Medicinal Chemistry Letters 2009 19 406~409
8、 Shi Zeng , Wei Liu , Zhi-yu Li , Qing-Long Guo et al, LYG-202, a new flavonoid with a piperazine substitution, shows antitumor effects in vivo and in vitro Biochemical and Biophysical Research Communications 2009 385 551–556（通讯作者）
9、 Xin Cao, Qi-Dong You*, Zhi-Yu Li*, et al Recent Progress of Src Family Kinase Inhibitors as Anticancer Agents Mini-Reviews in Medicinal Chemistry, 2008, 8, 1053~1063(通讯作者)
10、 Qi-Dong You,*, Zhi-Yu Li, Ji-Wang Chern*,et al Discovery of a Novel Series of Quinolone and Naphthyridine Derivatives as Potential Topoisomerase I Inhibitors by Scaffold Modification J、 Med、 Chem、 2009, 52, 5649–5661